Search

everythinglearnresearchcommunity

for

Search:↓

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Clofazimine may be effective for treating ashy dermatosis.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

The document explains how male reproductive hormones work and affect the body.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Substance from human umbilical cord blood cells promotes hair growth.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Medroxyprogesterone injections caused hair regrowth in some dogs with alopecia X.

Platelet Rich Plasma-Derived Extracellular Vesicles show promise for healing and regeneration but need standardized methods for consistent results.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

DHT stops hair regrowth in mice, similar to human hair loss.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Human hair protein modifications could potentially indicate heart disease risk.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.